首页> 外文期刊>Biochemical Pharmacology >Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
【24h】

Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.

机译:2-苄氧基苯甲醛抑制大鼠中性粒细胞中甲酰基-甲硫酰基-亮氨酰-苯丙氨酸诱导的超氧阴离子生成的细胞机制研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The inhibition of formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide anion (O2(.-)) generation by 2-benzyloxybenzaldehyde (CCY1a) was investigated in rat neutrophils, and the underlying mechanism of this inhibition was assessed. CCY1a concentration-dependently inhibited O2(.-) generation (IC(50)=18.5+/-4.3 microM). In cell-free systems, CCY1a failed to alter O2(.-) generation during dihydroxyfumaric acid autoxidation, in phorbol 12-myristate 13-acetate (PMA)-activated neutrophil particulate NADPH oxidase preparations, or during arachidonic acid-induced NADPH oxidase activation. CCY1a increased cellular cyclic AMP (cAMP) levels in a time- and concentration-dependent manner, and this cAMP-elevating effect was inhibited by the adenylyl cyclase inhibitor 9-(tetrahydro-2'-furyl)adenine (SQ22536), adenosine deaminase (ADA), and the adenosine receptor antagonist 8-(p-sulfophenyl)theophylline. In neutrophils, inhibition of O2(.-) generation by CCY1a was partially reversed by the protein kinase A inhibitor (9R,10S,12S)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy -1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-l][1,6]benzodiazocine-10-car boxylic acid, hexyl ester (KT5720). CCY1a did not affect fMLP-induced p38 mitogen-activated protein kinase phosphorylation, but concentration-dependently attenuated the phosphorylation of extracellular signal-regulated kinase (ERK) and Akt (IC(50) about 31.3 and 19.4 microM, respectively). The plateau phase, but not the initial spike, of fMLP-induced [Ca2+](i) changes was inhibited by CCY1a in a concentration-dependent manner. CCY1a inhibition of Ca2+ entry, ERK, and Akt phosphorylation was not prevented by SQ22536 or ADA. fMLP-induced phospholipase D (PLD) activation was inhibited by CCY1a (IC(50)=13.9+/-2.0 microM). ADA and KT5720 did not prevent the inhibition of PLD activation by CCY1a. Collectively, these results indicate that the inhibition by CCY1a of fMLP-induced O2(.-) generation in rat neutrophils can probably be attributed to the increase incAMP levels, and to the blockade of Ca2+ entry, suppression of Akt, and PLD activation via cAMP-independent mechanisms.
机译:在大鼠中性粒细胞中研究了2-苄氧基苯甲醛(CCY1a)对甲酰-甲硫酰基-亮氨酰-苯丙氨酸(fMLP)诱导的超氧阴离子(O2(.-))生成的抑制作用,并评估了这种抑制作用的潜在机制。 CCY1a浓度依赖性抑制O2(.-)生成(IC(50)= 18.5 +/- 4.3 microM)。在无细胞系统中,在佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)活化的中性粒细胞微粒NADPH氧化酶制剂中,或花生四烯酸诱导的NADPH氧化酶活化过程中,CCY1a在二羟基富马酸自氧化过程中未能改变O2(.-)的生成。 CCY1a以时间和浓度依赖性方式增加了细胞环AMP(cAMP)的水平,而腺苷酸环化酶抑制剂9-(四氢-2'-呋喃基)腺嘌呤(SQ22536),腺苷脱氨酶( ADA),以及腺苷受体拮抗剂8-(对-磺基苯基)茶碱。在中性粒细胞中,蛋白激酶A抑制剂(9R,10S,12S)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-被CCY1a抑制O2(.-)生成部分逆转。甲基-1-氧代-9,12-环氧-1H-二吲哚并[1,2,3-fg:3',2',1'-kl]吡咯并[3,4-l] [1,6]苯并重氮- 10羧基戊酸己酯(KT5720)。 CCY1a不会影响fMLP诱导的p38丝裂原激活的蛋白激酶磷酸化,但浓度依赖性地减弱了细胞外信号调节激酶(ERK)和Akt的磷酸化(IC(50)分别约为31.3和19.4 microM)。 fMLP诱导的[Ca2 +](i)变化的平台期,而不是初始峰值,受到CCY1a浓度依赖性的抑制。 SQ22536或ADA并未阻止CCY1a对Ca2 +进入,ERK和Akt磷酸化的抑制。 fMLP诱导的磷脂酶D(PLD)激活被CCY1a(IC(50)= 13.9 +/- 2.0 microM)抑制。 ADA和KT5720并未阻止CCY1a抑制PLD激活。总而言之,这些结果表明,CCY1a对大鼠中性粒细胞中fMLP诱导的O2(.-)生成的抑制作用可能归因于incAMP水平的增加,以及Ca2 +进入的阻滞,Akt的抑制以及通过cAMP激活PLD独立机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号